How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
86
PAHC Quote, Financials, Valuation and Earnings
Last price:
$50.02
Seasonality move
:
5.01%
Day range:
$43.17 - $50.05
52-week range:
$16.16 - $50.05
Dividend yield:
0.96%
P/E ratio:
22.17x
P/S ratio:
1.39x
P/B ratio:
6.10x
Volume:
982.3K
Avg. volume:
232.3K
1-year change:
123.51%
Market cap:
$2B
Revenue:
$1.3B
EPS (TTM):
$2.26
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp.
|
$355.6M | $0.67 | 5.06% | 35.5% | $46.00 |
|
ATRC
AtriCure, Inc.
|
$139.9M | -$0.05 | 12.94% | -34.79% | $52.78 |
|
BLFS
BioLife Solutions, Inc.
|
$24M | $0.01 | 5.9% | -98.07% | $32.44 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.18% | 74.57% | $108.66 |
|
RMD
ResMed, Inc.
|
$1.4B | $2.72 | 10.29% | 13.28% | $297.47 |
|
TMDX
TransMedics Group, Inc.
|
$155.3M | $0.37 | 17.75% | -1.53% | $144.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp.
|
$50.00 | $46.00 | $2B | 22.17x | $0.12 | 0.96% | 1.39x |
|
ATRC
AtriCure, Inc.
|
$36.20 | $52.78 | $1.8B | -- | $0.00 | 0% | 3.32x |
|
BLFS
BioLife Solutions, Inc.
|
$22.05 | $32.44 | $1.1B | -- | $0.00 | 0% | 10.55x |
|
BSX
Boston Scientific Corp.
|
$77.64 | $108.66 | $115.1B | 40.04x | $0.00 | 0% | 5.78x |
|
RMD
ResMed, Inc.
|
$267.05 | $297.47 | $38.9B | 26.40x | $0.60 | 0.85% | 7.27x |
|
TMDX
TransMedics Group, Inc.
|
$129.60 | $144.20 | $4.4B | 52.35x | $0.00 | 0% | 8.95x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp.
|
69.94% | 2.766 | 51.06% | 1.03x |
|
ATRC
AtriCure, Inc.
|
14.82% | 1.617 | 4.73% | 2.72x |
|
BLFS
BioLife Solutions, Inc.
|
5.52% | 0.391 | 1.69% | 3.31x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.200 | -- | 0.81x |
|
RMD
ResMed, Inc.
|
11.83% | 0.532 | 2.42% | 2.01x |
|
TMDX
TransMedics Group, Inc.
|
59.39% | 1.795 | 13.56% | 6.86x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp.
|
$132.3M | $54.4M | 8.65% | 31.92% | 14.55% | $8.3M |
|
ATRC
AtriCure, Inc.
|
$100.6M | $208K | -5.3% | -6.2% | 0.16% | $24.1M |
|
BLFS
BioLife Solutions, Inc.
|
$17.2M | -$89K | -4.73% | -5.11% | -0.32% | $2.8M |
|
BSX
Boston Scientific Corp.
|
$3.7B | $1B | 8.4% | 12.46% | 19.69% | $1.2B |
|
RMD
ResMed, Inc.
|
$867M | $500.3M | 22.22% | 25.44% | 35.16% | $305.2M |
|
TMDX
TransMedics Group, Inc.
|
$84.5M | $23.3M | 11.55% | 33.29% | 16.2% | $61.9M |
Phibro Animal Health Corp. vs. Competitors
-
Which has Higher Returns PAHC or ATRC?
AtriCure, Inc. has a net margin of 7.34% compared to Phibro Animal Health Corp.'s net margin of -0.2%. Phibro Animal Health Corp.'s return on equity of 31.92% beat AtriCure, Inc.'s return on equity of -6.2%.
Company Gross Margin Earnings Per Share Invested Capital PAHCPhibro Animal Health Corp.35.39% $0.67 $1.1B ATRCAtriCure, Inc.74.9% -$0.01 $559.4M -
What do Analysts Say About PAHC or ATRC?
Phibro Animal Health Corp. has a consensus price target of $46.00, signalling downside risk potential of -14%. On the other hand AtriCure, Inc. has an analysts' consensus of $52.78 which suggests that it could grow by 45.8%. Given that AtriCure, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe AtriCure, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings PAHCPhibro Animal Health Corp.0 2 0 ATRCAtriCure, Inc.5 0 0 -
Is PAHC or ATRC More Risky?
Phibro Animal Health Corp. has a beta of 0.801, which suggesting that the stock is 19.871% less volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.415, suggesting its more volatile than the S&P 500 by 41.514%.
-
Which is a Better Dividend Stock PAHC or ATRC?
Phibro Animal Health Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0.96%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Phibro Animal Health Corp. pays 40.46% of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PAHC or ATRC?
Phibro Animal Health Corp. quarterly revenues are $373.9M, which are larger than AtriCure, Inc. quarterly revenues of $134.3M. Phibro Animal Health Corp.'s net income of $27.5M is higher than AtriCure, Inc.'s net income of -$267K. Notably, Phibro Animal Health Corp.'s price-to-earnings ratio is 22.17x while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Phibro Animal Health Corp. is 1.39x versus 3.32x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PAHCPhibro Animal Health Corp.1.39x 22.17x $373.9M $27.5M ATRCAtriCure, Inc.3.32x -- $134.3M -$267K
-
Which has Higher Returns PAHC or BLFS?
BioLife Solutions, Inc. has a net margin of 7.34% compared to Phibro Animal Health Corp.'s net margin of 2.21%. Phibro Animal Health Corp.'s return on equity of 31.92% beat BioLife Solutions, Inc.'s return on equity of -5.11%.
Company Gross Margin Earnings Per Share Invested Capital PAHCPhibro Animal Health Corp.35.39% $0.67 $1.1B BLFSBioLife Solutions, Inc.61.36% $0.01 $374.4M -
What do Analysts Say About PAHC or BLFS?
Phibro Animal Health Corp. has a consensus price target of $46.00, signalling downside risk potential of -14%. On the other hand BioLife Solutions, Inc. has an analysts' consensus of $32.44 which suggests that it could grow by 43.12%. Given that BioLife Solutions, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe BioLife Solutions, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings PAHCPhibro Animal Health Corp.0 2 0 BLFSBioLife Solutions, Inc.9 0 0 -
Is PAHC or BLFS More Risky?
Phibro Animal Health Corp. has a beta of 0.801, which suggesting that the stock is 19.871% less volatile than S&P 500. In comparison BioLife Solutions, Inc. has a beta of 1.924, suggesting its more volatile than the S&P 500 by 92.427%.
-
Which is a Better Dividend Stock PAHC or BLFS?
Phibro Animal Health Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0.96%. BioLife Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Phibro Animal Health Corp. pays 40.46% of its earnings as a dividend. BioLife Solutions, Inc. pays out -- of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PAHC or BLFS?
Phibro Animal Health Corp. quarterly revenues are $373.9M, which are larger than BioLife Solutions, Inc. quarterly revenues of $28.1M. Phibro Animal Health Corp.'s net income of $27.5M is higher than BioLife Solutions, Inc.'s net income of $621K. Notably, Phibro Animal Health Corp.'s price-to-earnings ratio is 22.17x while BioLife Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Phibro Animal Health Corp. is 1.39x versus 10.55x for BioLife Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PAHCPhibro Animal Health Corp.1.39x 22.17x $373.9M $27.5M BLFSBioLife Solutions, Inc.10.55x -- $28.1M $621K
-
Which has Higher Returns PAHC or BSX?
Boston Scientific Corp. has a net margin of 7.34% compared to Phibro Animal Health Corp.'s net margin of 12.68%. Phibro Animal Health Corp.'s return on equity of 31.92% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital PAHCPhibro Animal Health Corp.35.39% $0.67 $1.1B BSXBoston Scientific Corp.69.58% $0.45 $35.7B -
What do Analysts Say About PAHC or BSX?
Phibro Animal Health Corp. has a consensus price target of $46.00, signalling downside risk potential of -14%. On the other hand Boston Scientific Corp. has an analysts' consensus of $108.66 which suggests that it could grow by 39.95%. Given that Boston Scientific Corp. has higher upside potential than Phibro Animal Health Corp., analysts believe Boston Scientific Corp. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings PAHCPhibro Animal Health Corp.0 2 0 BSXBoston Scientific Corp.26 0 0 -
Is PAHC or BSX More Risky?
Phibro Animal Health Corp. has a beta of 0.801, which suggesting that the stock is 19.871% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock PAHC or BSX?
Phibro Animal Health Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0.96%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Phibro Animal Health Corp. pays 40.46% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PAHC or BSX?
Phibro Animal Health Corp. quarterly revenues are $373.9M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Phibro Animal Health Corp.'s net income of $27.5M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Phibro Animal Health Corp.'s price-to-earnings ratio is 22.17x while Boston Scientific Corp.'s PE ratio is 40.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Phibro Animal Health Corp. is 1.39x versus 5.78x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PAHCPhibro Animal Health Corp.1.39x 22.17x $373.9M $27.5M BSXBoston Scientific Corp.5.78x 40.04x $5.3B $670M
-
Which has Higher Returns PAHC or RMD?
ResMed, Inc. has a net margin of 7.34% compared to Phibro Animal Health Corp.'s net margin of 27.59%. Phibro Animal Health Corp.'s return on equity of 31.92% beat ResMed, Inc.'s return on equity of 25.44%.
Company Gross Margin Earnings Per Share Invested Capital PAHCPhibro Animal Health Corp.35.39% $0.67 $1.1B RMDResMed, Inc.60.93% $2.68 $7.2B -
What do Analysts Say About PAHC or RMD?
Phibro Animal Health Corp. has a consensus price target of $46.00, signalling downside risk potential of -14%. On the other hand ResMed, Inc. has an analysts' consensus of $297.47 which suggests that it could grow by 11.39%. Given that ResMed, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe ResMed, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings PAHCPhibro Animal Health Corp.0 2 0 RMDResMed, Inc.8 7 1 -
Is PAHC or RMD More Risky?
Phibro Animal Health Corp. has a beta of 0.801, which suggesting that the stock is 19.871% less volatile than S&P 500. In comparison ResMed, Inc. has a beta of 0.869, suggesting its less volatile than the S&P 500 by 13.099%.
-
Which is a Better Dividend Stock PAHC or RMD?
Phibro Animal Health Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0.96%. ResMed, Inc. offers a yield of 0.85% to investors and pays a quarterly dividend of $0.60 per share. Phibro Animal Health Corp. pays 40.46% of its earnings as a dividend. ResMed, Inc. pays out 22.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PAHC or RMD?
Phibro Animal Health Corp. quarterly revenues are $373.9M, which are smaller than ResMed, Inc. quarterly revenues of $1.4B. Phibro Animal Health Corp.'s net income of $27.5M is lower than ResMed, Inc.'s net income of $392.6M. Notably, Phibro Animal Health Corp.'s price-to-earnings ratio is 22.17x while ResMed, Inc.'s PE ratio is 26.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Phibro Animal Health Corp. is 1.39x versus 7.27x for ResMed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PAHCPhibro Animal Health Corp.1.39x 22.17x $373.9M $27.5M RMDResMed, Inc.7.27x 26.40x $1.4B $392.6M
-
Which has Higher Returns PAHC or TMDX?
TransMedics Group, Inc. has a net margin of 7.34% compared to Phibro Animal Health Corp.'s net margin of 16.91%. Phibro Animal Health Corp.'s return on equity of 31.92% beat TransMedics Group, Inc.'s return on equity of 33.29%.
Company Gross Margin Earnings Per Share Invested Capital PAHCPhibro Animal Health Corp.35.39% $0.67 $1.1B TMDXTransMedics Group, Inc.58.74% $0.66 $874.5M -
What do Analysts Say About PAHC or TMDX?
Phibro Animal Health Corp. has a consensus price target of $46.00, signalling downside risk potential of -14%. On the other hand TransMedics Group, Inc. has an analysts' consensus of $144.20 which suggests that it could grow by 11.27%. Given that TransMedics Group, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe TransMedics Group, Inc. is more attractive than Phibro Animal Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings PAHCPhibro Animal Health Corp.0 2 0 TMDXTransMedics Group, Inc.7 3 0 -
Is PAHC or TMDX More Risky?
Phibro Animal Health Corp. has a beta of 0.801, which suggesting that the stock is 19.871% less volatile than S&P 500. In comparison TransMedics Group, Inc. has a beta of 2.059, suggesting its more volatile than the S&P 500 by 105.878%.
-
Which is a Better Dividend Stock PAHC or TMDX?
Phibro Animal Health Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0.96%. TransMedics Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Phibro Animal Health Corp. pays 40.46% of its earnings as a dividend. TransMedics Group, Inc. pays out -- of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PAHC or TMDX?
Phibro Animal Health Corp. quarterly revenues are $373.9M, which are larger than TransMedics Group, Inc. quarterly revenues of $143.8M. Phibro Animal Health Corp.'s net income of $27.5M is higher than TransMedics Group, Inc.'s net income of $24.3M. Notably, Phibro Animal Health Corp.'s price-to-earnings ratio is 22.17x while TransMedics Group, Inc.'s PE ratio is 52.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Phibro Animal Health Corp. is 1.39x versus 8.95x for TransMedics Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PAHCPhibro Animal Health Corp.1.39x 22.17x $373.9M $27.5M TMDXTransMedics Group, Inc.8.95x 52.35x $143.8M $24.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Sell
45
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
59
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 31x
Alerts
Buy
61
KELYB alert for Feb 6
Kelly Services, Inc. [KELYB] is up 243.2% over the past day.
Buy
86
PAHC alert for Feb 6
Phibro Animal Health Corp. [PAHC] is up 22% over the past day.
Sell
35
GDXU alert for Feb 6
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 19.48% over the past day.
